Company: BOLT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0000950170-25-054405
Chunk: 27

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 27
---
 in accordance with ASC 718. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. The amounts reported in this column reflect the accounting cost for these stock options and do not correspond to the actual economic value that may be received by the non-employee directors upon the exercise of the stock options or any sale of the underlying shares of common stock. Each non-employee director then continuing was granted a stock option to purchase 22,000 shares of common stock with an exercise price of $0.7682 per share on the date of our 2024 Annual Meeting of Stockholders. (2) Dr. Engleman resigned from the Board in May 2024. (3) In 2024, Drs. Engleman and Shah’s director compensation was paid to Vivo Capital VIII, LLC, or Vivo GP. Dr. Engleman is a voting member of Vivo GP and Dr. Shah is a managing member of Vivo PANDA, LLC. (4) Dr. Healy and Mr. Lee resigned from the Board in September 2024. (5) As of December 31, 2024, our non-employee directors held the following option awards:

| Name                        |     | Number    
 of Option 
 Awards    |         |
| Laura Berner                |     |           | 109,261 |
| Jakob Dupont, M.D.          |     |           |  66,984 |
| Edgar G. Engleman, M.D.     |     | —         |         |
| James I. Healy, M.D., Ph.D. |     | —         |         |
| Kathleen LaPorte            |     |           | 149,857 |
| Frank D. Lee                |     | —         |         |
| Richard A. Miller, M.D.     |     | —         |         |
| Brian O’Callaghan           |     |           | 136,071 |
| Nicole Onetto, M.D.         |     |           | 134,227 |
| Mahendra G. Shah, Ph.D.     |     |           |  97,000 |

(6) Dr. Miller retired from the Board upon the completion of his term at the 2024 Annual Meeting of Stockholders. (7) Dr. Shah resigned from the Board in December 2024. (8) Dr. Dupont was appointed to the Board in September 2024